Jump to content
RemedySpot.com

RE: kalawalla

Rate this topic


Guest guest

Recommended Posts

Hi all. Has anyone experimented with this suppliment by 'organic hope' ?

Cheers.

Helen x

>

>Reply-To: mscured

>To: mscured

>Subject: *MS Article* Molecule Key In MS?

>Date: Sun, 03 Dec 2006 23:58:45 -0000

>

>Hi

>

>I only know what is written below. Adam:

>

>Molecule linked to autoimmune disease relapses identified at Stanford

>

>Contact: Mitzi Baker

>mabaker@...

>

>Stanford University Medical Center

>

>Public release date: 3-Dec-2006

>

>Contact: Mitzi Baker

>mabaker@...

>

>Stanford University Medical Center

>

>

>STANFORD, Calif. -- The ebb and flow of such autoimmune diseases as

>multiple sclerosis, lupus and rheumatoid arthritis has long been a

>perplexing mystery. But new findings from the Stanford University School

>of Medicine bring scientists closer to solving the puzzle, identifying a

>molecule that appears to play a central role in relapses.

>

>The study, to be published in the Dec. 3 advance online edition of

>Nature Immunology, lays the groundwork for a way to determine when a

>relapse is about to occur, and could eventually lead to a treatment to

>prevent relapses. " Right now, there is no good blood test to evaluate

>when a person is going to have a flare-up, " said senior author Larry

>Steinman, MD, professor of neurology and neurological sciences. " If we

>had one, we might be able to give them prophylactic preventive

>medication. "

>

>The current study had its genesis five years ago: In a paper published

>in 2001 in the journal Science, Steinman found that a protein called

>osteopontin was abundant in multiple sclerosis-affected brain tissue,

>but not in normal tissue. Since then, other groups have confirmed that

>osteopontin is elevated just prior to and during a relapse of the

>disease in M.S. patients.

>

>Although the protein had been known to play a role in bone growth, it

>was unclear why it would be associated with multiple sclerosis, which

>results when the immune system attacks the protective myelin sheath

>surrounding nerve cells.

>

>To explore this question, Eun Mi Hur, PhD, who was then a graduate

>student in Steinman's lab, began using a mouse model of multiple

>sclerosis (experimental autoimmune encephalomyletis, or EAE) to

>investigate how osteopontin could cause these flare-ups. She and

>Steinman gave osteopontin to mice that had already experienced

>paralysis, similar to that of an M.S. patient, and found that the mice

>then experienced a relapse of the disease.

>

>The researchers also found that the relapse would occur sometimes in an

>area of the brain other than the site of the original attack. For

>example, after receiving the osteopontin, some animals that had

>previously suffered paralysis became blind from a condition called optic

>neuritis. One feature of multiple sclerosis is that the flare-ups can

>affect different parts of the nervous system at different times.

>

> " When I saw that all mice with EAE relapsed and died from the disease

>after about a month of osteopontin administration, I was surprised, "

>said Hur, the study's first author who is now a postdoctoral scholar at

>Caltech. " I got a strong belief that a high level of osteopontin in

>patients' blood and tissue is a major contributor of the relapse and

>progression of the disease. "

>

>Through the mouse studies and molecular characterizations, Hur and

>Steinman showed that osteopontin - produced by immune cells and brain

>cells themselves - promotes the survival of the T cells that carry out

>the damaging attack on myelin; by increasing the number of these T

>cells, osteopontin increases their destructive potential. These results

>could be applicable to many other autoimmune diseases, including

>rheumatoid arthritis, type-1 diabetes and lupus.

>

>Indeed, the effect of osteopontin may severely alter the way the immune

>system works. Normally, after the immune system does its job -

>eradicating a microbe, for instance - the response is then dialed down.

>If this didn't happen, the immune response would go on indefinitely.

>Imagine a cold or an attack of poison oak that would last forever.

>

>One of the ways that the immune response is muffled is that the

>activated T cells die in a process known as apoptosis. That is precisely

>what osteopontin seems to prevent. Osteopontin lets the T cells linger

>in the blood, ready to attack again. " We don't know exactly what

>triggers that new attack but the cells certainly are around and ready to

>do it, " said Steinman. So scientists now face the challenge of figuring

>out how and why osteopontin is produced. " We're back to the

>chicken-and-the-egg problem, " said Steinman. " We know the egg, so why

>did the chicken lay it " That is a trickier problem to work out. "

>

>Even without knowing the answer to that question, there is one inviting

>practical use of their observations: Osteopontin could be used as a

>marker of an impending relapse. What's more, if the protein could be

>blocked, it might thwart the relapse from ever occurring. Steinman's lab

>is working to develop antibodies to inactivate the protein's effect.

> " It's still a long road between saying we want to do it and getting the

>antibodies, getting it approved by the FDA and getting it tested, " said

>Steinman, " but we are determined to do that. "

>

>Still, Steinman offered a caveat. Researchers may find that blocking

>osteopontin has undesirable side effects. The protein may serve other

>purposes in addition to promoting survival of immune cells. It could

>also be vital to the body's ability to produce myelin, a function that

>could cause severe problems if disrupted. " Like a lot of important

>biological molecules, osteopontin has a Janus-like quality - a bad side

>and a good side, " Steinman said. " We're going to be extremely lucky if

>we give the antibody opposing osteopontin and derive just the good side:

>We stop the autoimmune attack but don't interfere with the survival of

>other cells. "

>

>Further study will determine whether thwarting osteopontin's effect

>yields new types of treatments for autoimmune diseases, but regardless,

>it is likely to lead to discoveries in a host of areas. " I think

>osteopontin will turn out to be important in a lot of processes,

>spanning autoimmunity to stem cells, " said Steinman. " It's probably

>going to turn out to be a very basic growth factor. "

>###

>

>EMBARGOED FOR RELEASE UNTIL: Sunday, Dec. 3, 2006, at 11 a.m. to

>coincide with advance online publication in Nature Immunology BROADCAST

>MEDIA CONTACT: Margarita Gallardo at

>(mjgallardo@...)

>

>This study was supported by the National Institutes of Health, the

>National Multiple Sclerosis Society, the Phil N. Trust, a Stanford

>Graduate Fellowship, a Korean Government Overseas Scholarship and a

>National Multiple Sclerosis Society Career Transitional Award. Other

>authors of the study are: Sawsan Youssef, PhD, a postdoctoral scholar in

>neurology and neurological sciences; M. Haws, an undergraduate at

>Brigham Young University; Zhang, a Stanford undergraduate, and

> Sobel, MD, professor of pathology.

>

>Stanford University Medical Center integrates research, medical

>education and patient care at its three institutions - Stanford

>University School of Medicine, Stanford Hospital & Clinics and Lucile

>Packard Children's Hospital at Stanford. For more information, please

>visit the Web site of the medical center's Office of Communication &

>Public Affairs at http://mednews.stanford.edu.

>http://www.eurekalert.org/pub_releases/2006-12/sumc-mlt120106.php

>

>

_________________________________________________________________

Express yourself instantly with MSN Messenger! Download today it's FREE!

http://messenger.msn.click-url.com/go/onm00200471ave/direct/01/

Link to comment
Share on other sites

Hello Helen,

My name is . I have used OH Kalawalla for about 6 months.

It showed good results, but it did not do what I needed, which was to

take away all my ms symptoms. For me, the best approach is not look

for a one pill does it all approach. What the rest of the more sr.

members of this group have been saying is the route I have decided to

take. Meaning, cleansing and then detox (heavy metals and others),

raw foods etc.. .

>

> Hi all. Has anyone experimented with this suppliment by 'organic hope' ?

> Cheers.

> Helen x

>

>

> >

> >Reply-To: mscured

> >To: mscured

> >Subject: *MS Article* Molecule Key In MS?

> >Date: Sun, 03 Dec 2006 23:58:45 -0000

> >

> >Hi

> >

> >I only know what is written below. Adam:

> >

> >Molecule linked to autoimmune disease relapses identified at Stanford

> >

> >Contact: Mitzi Baker

> >mabaker@

> >

> >Stanford University Medical Center

> >

> >Public release date: 3-Dec-2006

> >

> >Contact: Mitzi Baker

> >mabaker@

> >

> >Stanford University Medical Center

> >

> >

> >STANFORD, Calif. -- The ebb and flow of such autoimmune diseases as

> >multiple sclerosis, lupus and rheumatoid arthritis has long been a

> >perplexing mystery. But new findings from the Stanford University

School

> >of Medicine bring scientists closer to solving the puzzle,

identifying a

> >molecule that appears to play a central role in relapses.

> >

> >The study, to be published in the Dec. 3 advance online edition of

> >Nature Immunology, lays the groundwork for a way to determine when a

> >relapse is about to occur, and could eventually lead to a treatment to

> >prevent relapses. " Right now, there is no good blood test to evaluate

> >when a person is going to have a flare-up, " said senior author Larry

> >Steinman, MD, professor of neurology and neurological sciences. " If we

> >had one, we might be able to give them prophylactic preventive

> >medication. "

> >

> >The current study had its genesis five years ago: In a paper published

> >in 2001 in the journal Science, Steinman found that a protein called

> >osteopontin was abundant in multiple sclerosis-affected brain tissue,

> >but not in normal tissue. Since then, other groups have confirmed that

> >osteopontin is elevated just prior to and during a relapse of the

> >disease in M.S. patients.

> >

> >Although the protein had been known to play a role in bone growth, it

> >was unclear why it would be associated with multiple sclerosis, which

> >results when the immune system attacks the protective myelin sheath

> >surrounding nerve cells.

> >

> >To explore this question, Eun Mi Hur, PhD, who was then a graduate

> >student in Steinman's lab, began using a mouse model of multiple

> >sclerosis (experimental autoimmune encephalomyletis, or EAE) to

> >investigate how osteopontin could cause these flare-ups. She and

> >Steinman gave osteopontin to mice that had already experienced

> >paralysis, similar to that of an M.S. patient, and found that the mice

> >then experienced a relapse of the disease.

> >

> >The researchers also found that the relapse would occur sometimes in an

> >area of the brain other than the site of the original attack. For

> >example, after receiving the osteopontin, some animals that had

> >previously suffered paralysis became blind from a condition called

optic

> >neuritis. One feature of multiple sclerosis is that the flare-ups can

> >affect different parts of the nervous system at different times.

> >

> > " When I saw that all mice with EAE relapsed and died from the disease

> >after about a month of osteopontin administration, I was surprised, "

> >said Hur, the study's first author who is now a postdoctoral scholar at

> >Caltech. " I got a strong belief that a high level of osteopontin in

> >patients' blood and tissue is a major contributor of the relapse and

> >progression of the disease. "

> >

> >Through the mouse studies and molecular characterizations, Hur and

> >Steinman showed that osteopontin - produced by immune cells and brain

> >cells themselves - promotes the survival of the T cells that carry out

> >the damaging attack on myelin; by increasing the number of these T

> >cells, osteopontin increases their destructive potential. These results

> >could be applicable to many other autoimmune diseases, including

> >rheumatoid arthritis, type-1 diabetes and lupus.

> >

> >Indeed, the effect of osteopontin may severely alter the way the immune

> >system works. Normally, after the immune system does its job -

> >eradicating a microbe, for instance - the response is then dialed down.

> >If this didn't happen, the immune response would go on indefinitely.

> >Imagine a cold or an attack of poison oak that would last forever.

> >

> >One of the ways that the immune response is muffled is that the

> >activated T cells die in a process known as apoptosis. That is

precisely

> >what osteopontin seems to prevent. Osteopontin lets the T cells linger

> >in the blood, ready to attack again. " We don't know exactly what

> >triggers that new attack but the cells certainly are around and

ready to

> >do it, " said Steinman. So scientists now face the challenge of figuring

> >out how and why osteopontin is produced. " We're back to the

> >chicken-and-the-egg problem, " said Steinman. " We know the egg, so why

> >did the chicken lay it " That is a trickier problem to work out. "

> >

> >Even without knowing the answer to that question, there is one inviting

> >practical use of their observations: Osteopontin could be used as a

> >marker of an impending relapse. What's more, if the protein could be

> >blocked, it might thwart the relapse from ever occurring.

Steinman's lab

> >is working to develop antibodies to inactivate the protein's effect.

> > " It's still a long road between saying we want to do it and getting the

> >antibodies, getting it approved by the FDA and getting it tested, " said

> >Steinman, " but we are determined to do that. "

> >

> >Still, Steinman offered a caveat. Researchers may find that blocking

> >osteopontin has undesirable side effects. The protein may serve other

> >purposes in addition to promoting survival of immune cells. It could

> >also be vital to the body's ability to produce myelin, a function that

> >could cause severe problems if disrupted. " Like a lot of important

> >biological molecules, osteopontin has a Janus-like quality - a bad side

> >and a good side, " Steinman said. " We're going to be extremely lucky if

> >we give the antibody opposing osteopontin and derive just the good

side:

> >We stop the autoimmune attack but don't interfere with the survival of

> >other cells. "

> >

> >Further study will determine whether thwarting osteopontin's effect

> >yields new types of treatments for autoimmune diseases, but regardless,

> >it is likely to lead to discoveries in a host of areas. " I think

> >osteopontin will turn out to be important in a lot of processes,

> >spanning autoimmunity to stem cells, " said Steinman. " It's probably

> >going to turn out to be a very basic growth factor. "

> >###

> >

> >EMBARGOED FOR RELEASE UNTIL: Sunday, Dec. 3, 2006, at 11 a.m. to

> >coincide with advance online publication in Nature Immunology BROADCAST

> >MEDIA CONTACT: Margarita Gallardo at

> >(mjgallardo@)

> >

> >This study was supported by the National Institutes of Health, the

> >National Multiple Sclerosis Society, the Phil N. Trust, a

Stanford

> >Graduate Fellowship, a Korean Government Overseas Scholarship and a

> >National Multiple Sclerosis Society Career Transitional Award. Other

> >authors of the study are: Sawsan Youssef, PhD, a postdoctoral

scholar in

> >neurology and neurological sciences; M. Haws, an

undergraduate at

> >Brigham Young University; Zhang, a Stanford undergraduate, and

> > Sobel, MD, professor of pathology.

> >

> >Stanford University Medical Center integrates research, medical

> >education and patient care at its three institutions - Stanford

> >University School of Medicine, Stanford Hospital & Clinics and Lucile

> >Packard Children's Hospital at Stanford. For more information, please

> >visit the Web site of the medical center's Office of Communication &

> >Public Affairs at http://mednews.stanford.edu.

> >http://www.eurekalert.org/pub_releases/2006-12/sumc-mlt120106.php

> >

> >

>

> _________________________________________________________________

> Express yourself instantly with MSN Messenger! Download today it's

FREE!

> http://messenger.msn.click-url.com/go/onm00200471ave/direct/01/

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...